Carl Hull

CEO

Director

Ortho Clinical Diagnostics Holdings plc Maravai Lifesciences Holdings, Inc.

Insider activity · 24 months1 buy0 salesCumulative net flow

Nov 24 · 1 buy · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (1 ops.)

€921k

▼ Sales (0 ops.)

—

Latest filing published 12 Nov 2024 for Maravai Lifesciences Holdings, INC., €921k. Read the official filing

Filing timeline

BuySale

Carl Hull

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Carl Hull: trading record in brief

This profile gathers the share dealings of Carl Hull across 2 companies, led by Maravai Lifesciences Holdings, Inc. and Ortho Clinical Diagnostics Holdings plc. Between 3 May 2021 and 11 November 2024, the trades on record add up to 9 filings.

The open-market record is one-sided, with 1 purchase worth €921k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 7 share grants. So far in 2024, the count stands at 1 purchase and no sales.

The newest entry dates from 12 November 2024: an open-market purchase of €921k, in Maravai Lifesciences Holdings, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.